Browse By

Daily Archives: February 9, 2020

[Biotech&Pharma] Cytokinetics Announces Publication Relating to Design of GALACTIC-HF, a Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure

Second Interim Analysis in GALACTIC-HF Expected to Occur in Q1 2020 Topline Results Expected in Q4 2020 SOUTH SAN FRANCISCO, Calif., Feb. 06, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (NASDAQ:CYTK) today announced the publication of a manuscript relating to the design of GALACTIC-HF (Global Approach